Joseph A. Tyndall - May 22, 2025 Form 4 Insider Report for Axogen, Inc. (AXGN)

Role
Director
Signature
/s/ Marc Began as attorny-in-fact for Joseph A. Tyndall
Stock symbol
AXGN
Transactions as of
May 22, 2025
Transactions value $
-$224,694
Form type
4
Date filed
5/23/2025, 04:32 PM
Previous filing
May 23, 2025
Next filing
Jun 11, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
TYNDALL JOSEPH A. Director C/O AXOGEN, INC. 13631 PROGRESS BLVD.,, SUITE 400, ALACHUA /s/ Marc Began as attorny-in-fact for Joseph A. Tyndall 2025-05-23 0001955281

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXGN Common Stock Options Exercise $81K +12.9K +56.97% $6.30 35.4K May 22, 2025 Direct
transaction AXGN Common Stock Sale -$144K -12.9K -36.29% $11.20 22.6K May 22, 2025 Direct F1
transaction AXGN Common Stock Sale -$80.8K -7.21K -31.97% $11.20 15.3K May 22, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXGN Stock Option (right to purchase) Options Exercise -$81K -12.9K -62.88% $6.30 7.59K May 22, 2025 Common Stock 12.9K $6.30 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares of common stock were sold in multiple transactions at prices ranging from $11.15 to $11.31, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. These shares of common stock were sold in multiple transactions at prices ranging from $11.15 to $11.29, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Options vested on the first anniversary of the grant date, which was September 1, 2023.